ArticleAnnals of the rheumatic diseases2019

Comment on: 'Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand

No numbers read from the abstract.

Not cited yet